Health Care
Commentary
Reforms Should Empower Healthcare Entrepreneurs Not Bureaucrats
Unaffordable healthcare is an unnecessary access barrier that has burdened too many people with financially ruinous debt. Worsening these outcomes, healthcare waste is excessive, and productivity is stagnating. In response, more and more policymakers are favoring reforms that would nationalize healthcare or create a public health insurance option. Further socializing ...
Wayne Winegarden
July 13, 2020
Coronavirus
Dr. Henry Miller and Lars Larson Talk COVID Surge and PPE
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to talk about the latest changes in the coronavirus, or COVID-19, including the developments in the American southwest including steps the public can take to stop the spread of coronavirus and the dwindling number of hospital beds. Miller talks about why ...
Henry Miller, M.S., M.D.
July 12, 2020
Commentary
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Sally C. Pipes
July 12, 2020
Commentary
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Sally C. Pipes
July 12, 2020
Commentary
Telehealth’s Success During COVID-19 Shows Need to Empower Health Care Innovators
The COVID-19 crisis has tested America’s health care system like no other event in recent memory. One irony during this pandemic is that America has actually experienced the promise of health care innovation in an important way, namely through telehealth. Telehealth allows patients to talk with their doctors online using ...
Wayne Winegarden
July 9, 2020
Health Care
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Sally C. Pipes
July 9, 2020
Business & Economics
Wayne Winegarden – Empowering Entrepreneurs to Address America’s Health Care Challenges
PRI Senior Fellow in Business and Economics Dr. Wayne Winegarden joins us to discuss the latest study in the “Breaking Down Barriers to Opportunity” series, which makes the case that future medical innovation will be hindered unless state and federal policymakers embrace health care entrepreneurship.
Pacific Research Institute
July 6, 2020
Coronavirus
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Henry Miller, M.S., M.D.
July 6, 2020
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Sally C. Pipes
July 6, 2020
Commentary
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
Sally C. Pipes
July 6, 2020
Reforms Should Empower Healthcare Entrepreneurs Not Bureaucrats
Unaffordable healthcare is an unnecessary access barrier that has burdened too many people with financially ruinous debt. Worsening these outcomes, healthcare waste is excessive, and productivity is stagnating. In response, more and more policymakers are favoring reforms that would nationalize healthcare or create a public health insurance option. Further socializing ...
Dr. Henry Miller and Lars Larson Talk COVID Surge and PPE
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to talk about the latest changes in the coronavirus, or COVID-19, including the developments in the American southwest including steps the public can take to stop the spread of coronavirus and the dwindling number of hospital beds. Miller talks about why ...
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Telehealth’s Success During COVID-19 Shows Need to Empower Health Care Innovators
The COVID-19 crisis has tested America’s health care system like no other event in recent memory. One irony during this pandemic is that America has actually experienced the promise of health care innovation in an important way, namely through telehealth. Telehealth allows patients to talk with their doctors online using ...
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Wayne Winegarden – Empowering Entrepreneurs to Address America’s Health Care Challenges
PRI Senior Fellow in Business and Economics Dr. Wayne Winegarden joins us to discuss the latest study in the “Breaking Down Barriers to Opportunity” series, which makes the case that future medical innovation will be hindered unless state and federal policymakers embrace health care entrepreneurship.
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...